Document is current
Any future updates will be listed below
-
Authors
Schneegans, Svenja
Löptien, Jana
Mojzisch, Angelika
Loreth, Desirée
Kretz, Oliver
Raschdorf, Christoph
Hanssen, Annkathrin
Gocke, Antonia
Siebels, Bente
Gunasekaran, Karthikeyan
Ding, Yi
Oliveira-Ferrer, Leticia
Brylka, Laura
Schinke, Thorsten
Schlüter, Hartmut
Paatero, Ilkka
Voß, Hannah
Werner, Stefan
Pantel, Klaus
Wikman, Harriet http://orcid.org/0000-0001-6862-0888
-
Funding
Funding for this research was provided by:
Hamburger Krebsgesellschaft
Wilhelm Sander-Stiftung (2017.142.1, 2017.142.1)
Erich und Gertrud Roggenbuck-Stiftung
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 20 March 2024
First Online: 11 April 2024
Declarations
:
: Zebrafish experiments were carried out under license ESAVI/31414/2020 and approved by the Project Authorization Board of the Regional State Administrative Agency for Southern Finland.Mouse experiments were carried out under licence N034/2018 and approved by the Authority for Health and Consumer Protection of the City of Hamburg. As intracardial injections were performed, the tumor burden could only be assessed by BLI and body weight (not allowed to lose > 10%). All animals were sacrificed simultaneously when first BLI signal was seen, none reached a weight loss of 10%.
: Not applicable.
: The authors declare that they have no competing interests.
